Diabetes Research Network Professor Azeem Majeed Imperial College, London

Aims of the Diabetes Research Network Supporting optimal approaches to disease prevention, diagnosis and treatment (emphasis on clinical trials)

Millions of cases of diabetes in 2000 and projections for 2030, with projected percent changes

Department of Health Statistics for England, World Health Organization. Integrated Management of Cardiovascular Risk All M F CVD mortality % Premature CVD is main cause of death in Type 2 diabetes General population Diabetes

The UK Clinical Research Collaboration The UK CRC is a partnership of organisations working with key stakeholders to effect change The UKCRC is also a new way of working

Clinical research networks Experimental medicine Clinical research programme Research workforce (including academic medical careers) Regulation UK Clinical Research Collaboration Research for Patient Benefit Working Party (2004)

UK Clinical Research Network (UKCRN) NHS Infrastructure (research staff, nurses etc.) Currently 7 (+1) networks Working with industry Interfaces with other funders

Background to creation of disease specific networks Designed to support optimal approaches to disease prevention, diagnosis and treatment (emphasis on clinical trials) Topic-specific networks in cancer, stroke, neurodegenerative diseases, mental health, medicines for children, diabetes

Local Research Networks SW Peninsula Thames Valley North West London North East London Eastern England South East Midlands North West North & East Cumbria

NW London: Organisations

NW London LRN: Core Team

Control of HBA1c in patients with diabetes in general practices in NW London in

Key points Diabetes is a key chronic disease for primary care clinicians Research has a major role in improving diabetes care and making more effective treatments available to patients Engaging patients and primary health care teams will be essential

Diabetes care in Mauritius Who provides diabetes care in Mauritius: GPs, specialists, nurses? How is quality of care measured? What are the current strengths of diabetes care? What are the weaknesses? How can quality measurement, clinical audit and research be implemented?